Pharmacokinetics and pharmacodynamics of a new intranasal midazolam formulation in healthy volunteers

Anesthesia and Analgesia

Volumn 103, Issue 2, 2006, Pages 344-349

  Wermeling, Daniel P ^a   Record, Kenneth A ^a   Kelly, Thomas H ^a   Archer, Sanford M ^b   Clinch, Thomas ^c   Rudy, Anita C ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Intranasal Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM;

ADULT; APNEA; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BLURRED VISION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HUMAN; LACRIMATION DISORDER; LARYNX SPASM; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NOSE CONGESTION; PHARMACODYNAMICS; PHARYNX DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SINGLE DRUG DOSE; TASTE DISORDER; WHEEZING;

EID: 33746507433     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000226150.90317.16     Document Type: Article

References (15)

1. Folayan MO, Faponle A, Lamikanra A. Seminars on controversial issues. A review of the pharmacological approach to the management of dental anxiety in children. Int J Paediatr Dent 2002;12:347-54.
2. Kain ZN, Mayes LC, Bell C, et al. Premedication in the United States: a status report. Anesth Analg 1997;84:427-32.
3. Wilton NCT, Leigh J, Rosen DR, Pandit UA. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 1988;69:972-5.
4. Zedie N, Amory D, Wagner BHJ, O'Hara DA. Comparison of intranasal midazolam and sufentanil premedication in pediatric outpatients. Clin Pharmacol Ther 1996;59:341-8.
5. Rey E, Delaunay L, Pons G, et al. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991;41:355-7.
6. Walbergh EJ, Wills RJ, Eckhert J. Plasma concentration of midazolam in children following intranasal administration. Anesthesiology 1991;74:233-5.
7. Bjorkman S, Rigemar G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 1997;79:575-80.
8. Burstein AH, Modica R, Hatton M, et al. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol 1997;37:711-8.
9. Gudmundsdottir H, Sigurjonsdottir JF, Masson M, et al. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie 2001;56:963-6.
10. Loftsson T, Gudmundsdottir H, Sigurjonsdottir JF, et al. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm 2001;212:29-40.
11. Knoester PD, Jonker DM, Van Der Hoeven RT, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray: a study in healthy volunteers. Br J Clin Pharmacol 2002;53:501-7.
12. Coda BA, Rudy AC, Archer SM, Wermeling DP. Pharmacokinetics and bioavailability of single dose intranasal hydromorphone hydrochloride in healthy volunteers. Anesth Analg 2003;97:117-23.
13. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982: 409-17.
14. McLeod DR, Griffiths RR, Bigelow GE, et al. An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 1982;14:463-6.
15. Hoddes E, Zarcone V, Smythe H, et al. Quantification of sleepiness: a new approach. Psychophysiology 1973;10:431-6.